How important is subjective well-being for patients? A qualitative interview study of people with psoriasis
Standard
How important is subjective well-being for patients? A qualitative interview study of people with psoriasis. / Newi, Antonia-Luise; Tsianakas, Athanasios; von Martial, Sophia; Sommer, Rachel; Blome, Christine.
In: QUAL LIFE RES, Vol. 31, No. 12, 12.2022, p. 3355-3363.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - How important is subjective well-being for patients? A qualitative interview study of people with psoriasis
AU - Newi, Antonia-Luise
AU - Tsianakas, Athanasios
AU - von Martial, Sophia
AU - Sommer, Rachel
AU - Blome, Christine
N1 - © 2022. The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - PURPOSE: This qualitative study aimed to investigate the importance of subjective well-being (SWB) as an outcome of psoriasis treatment from patient's perspective. We focused on the affective component of SWB as assessed with the Daily Experience Sampling Questionnaire (DESQ), a validated daily diary.METHODS: Semi-structured qualitative telephone interviews were conducted with in-patients of a dermatological rehabilitation clinic, after participants had completed the DESQ for up to seven days to get familiar with the concept of SWB. Patients were asked to reflect on the importance of SWB as treatment goal and on its relative importance as compared with other treatment outcomes. We also addressed whether SWB could be an indirect measure of benefit in that it reflects other important outcomes. Transcripts were analyzed using content analysis.RESULTS: Eleven patients participated (24-63 years, mean 53 years, 8 male, 3 female). Participants uniformly confirmed that changes in SWB reflected treatment benefit. All but one considered SWB to be a central aspect of treatment benefit-either as the most important treatment goal or as an indirect benefit indicator. In particular, participants described positive associations of SWB with other outcomes, such as symptoms. They reported that both the disease and the medical treatment had an impact on their SWB, which was reflected in the DESQ.CONCLUSION: Our findings suggest that SWB is a relevant indicator of treatment benefit for patients with psoriasis. Therefore, SWB measures, such as the DESQ, could be used to operationalize patient-relevant benefit of psoriasis treatment, complementing outcome measures currently used.
AB - PURPOSE: This qualitative study aimed to investigate the importance of subjective well-being (SWB) as an outcome of psoriasis treatment from patient's perspective. We focused on the affective component of SWB as assessed with the Daily Experience Sampling Questionnaire (DESQ), a validated daily diary.METHODS: Semi-structured qualitative telephone interviews were conducted with in-patients of a dermatological rehabilitation clinic, after participants had completed the DESQ for up to seven days to get familiar with the concept of SWB. Patients were asked to reflect on the importance of SWB as treatment goal and on its relative importance as compared with other treatment outcomes. We also addressed whether SWB could be an indirect measure of benefit in that it reflects other important outcomes. Transcripts were analyzed using content analysis.RESULTS: Eleven patients participated (24-63 years, mean 53 years, 8 male, 3 female). Participants uniformly confirmed that changes in SWB reflected treatment benefit. All but one considered SWB to be a central aspect of treatment benefit-either as the most important treatment goal or as an indirect benefit indicator. In particular, participants described positive associations of SWB with other outcomes, such as symptoms. They reported that both the disease and the medical treatment had an impact on their SWB, which was reflected in the DESQ.CONCLUSION: Our findings suggest that SWB is a relevant indicator of treatment benefit for patients with psoriasis. Therefore, SWB measures, such as the DESQ, could be used to operationalize patient-relevant benefit of psoriasis treatment, complementing outcome measures currently used.
KW - Humans
KW - Male
KW - Female
KW - Quality of Life/psychology
KW - Outcome Assessment, Health Care/methods
KW - Qualitative Research
KW - Treatment Outcome
KW - Psoriasis/drug therapy
U2 - 10.1007/s11136-022-03189-w
DO - 10.1007/s11136-022-03189-w
M3 - SCORING: Journal article
C2 - 35948788
VL - 31
SP - 3355
EP - 3363
JO - QUAL LIFE RES
JF - QUAL LIFE RES
SN - 0962-9343
IS - 12
ER -